Previous Next

RECURRENT ISSUES IN NEUROANESTHESIA

Several basic elements of neurosurgical/neuroanesthetic management are recurrent and should be discussed and agreed on with the surgical team at the outset of every neurosurgical procedure. The list will vary with the procedure and may include the intended surgical position and requisite positioning aids; intentions with respect to the use of steroids, diuretics, anticonvulsants, and antibiotics; the surgeon's perception of the "tightness" of the intracranial space and the remaining intracranial compliance reserve; appropriate objectives for the management of blood pressure, carbon dioxide tension, and body temperature; anticipated blood loss; the intended use of neurophysiologic monitoring (which may impose constraints on the use of anesthetics or muscle relaxants, or both); and occasionally, the perceived risk of air embolization. The considerations driving the decisions made about these issues are presented in this section. One additional recurrent issue, brain protection, is discussed briefly in the section "Aneurysms and Arteriovenous Malformations" and in detail in Chapter 21 .

Control of Intracranial Pressure/Brain Relaxation

The necessity of preventing increases in intracranial pressure (ICP) or reducing an ICP that is already elevated is recurrent in neuroanesthesia. When the cranium is closed, the objective is to maintain adequate cerebral perfusion pressure (CPP) (CPP = mean arterial pressure [MAP] − ICP) and prevent the herniation of brain tissue between intracranial compartments or through the foramen magnum ( Fig. 53-1 ). When the cranium is open, the issue may be one of providing relaxation of the intracranial contents to facilitate surgical access or, in extreme circumstances, reverse the process of brain herniation through a craniotomy (see Fig. 53-1 ). The principles that apply are similar whether the cranium is open or closed.


2128


Figure 53-1 Schematic representation of various herniation pathways: 1, subfalcine; 2, uncal (transtentorial); 3, cerebellar; and 4, transcalvarial. (Reprinted, by permission, from Fishman RA: Brain edema. N Engl J Med 293:706, 1975.)

The various clinical indicators of increased ICP include headache (particularly a postural headache that awakens the patient at night), nausea and vomiting, blurred vision, somnolence, and papilledema. Suggestive findings on computed tomography (CT) include midline shift, obliteration of the basal cisterns, loss of sulci, ventricular effacement (or enlarged ventricles in the event of hydrocephalus), and edema. Edema appears on a CT scan as a region of hypodensity. The basal cisterns appear on CT as a black (fluid) halo around the upper end of the brainstem ( Fig. 53-2 ). They include the interpeduncular cistern, which lies


Figure 53-2 Computed tomography scan depicting normal (left) and compressed (right) basal cisterns. The basal, or perimesencephalic, cerebrospinal fluid space consists of the interpeduncular cistern (anterior), the ambient cisterns (lateral), and the quadrigeminal cisterns (posterior). In the right panel, in a patient with diffuse cerebral swelling (as a result of sagittal sinus thrombosis), the cisterns have been obliterated. (Courtesy of Ivan Petrovitch, M.D.)

between the two cerebral peduncles, the quadrigeminal cistern, which overlies the four colliculi, and the ambient cisterns, which lie lateral to the cerebral peduncles.

Figure 53-3 presents the pressure-volume relationship of the intracranial space. The plateau phase occurring at low volumes reveals that the intracranial space is not a completely closed one and that there is some compensatory latitude. Compensation is accomplished principally by the translocation of cerebrospinal fluid (CSF) and venous blood to the spinal CSF space and the extracranial veins, respectively. Ultimately, when the compensatory potential is exhausted, even tiny increments in volume of the intracranial contents can result in substantial increases in ICP. These increases have the potential to result in either herniation of brain tissue from one compartment to another (or into the surgical field) (see Fig. 53-1 ), with resultant mechanical injury to brain tissue, or reduction in perfusion pressure with a concomitant ischemic injury.

Several variables can interact to cause or aggravate intracranial hypertension ( Fig. 53-4 ). For clinicians faced with the problem of managing increased ICP, the objective is, broadly speaking, to reduce the volume of the intracranial contents. For mnemonic purposes, when developing a clinical approach, the clinician can divide the intracranial space into four subcompartments ( Table 53-1 ): cells (including neurons, glia, tumors, and extravasated collections of blood), fluid (intracellular and extracellular), CSF, and blood. Again for mnemonic purposes, the blood compartment can be subdivided into venous and arterial components. It is this last compartment, the blood compartment, that is most amenable to rapid manipulation by the clinician, and accordingly, it is the compartment to which the greatest level of attention is ultimately directed.


Figure 53-3 Intracranial pressure-volume relationship. The horizontal portion of the curve indicates that initially there is some latitude for compensation in the face of an expanding intracranial lesion. This compensation is accomplished largely by displacement of cerebrospinal fluid (CSF) and venous blood from the intracranial to the extracranial spaces. Once the compensatory latitudes are exhausted, small increments in volume result in large increases in intracranial pressure with the associated hazards of herniation or decreased cerebral perfusion pressure (CPP) resulting in ischemia.


2129


Figure 53-4 Pathophysiology of intracranial hypertension. The figure depicts the manner in which increases in the volumes of any or all of the four intracranial compartments, blood, cerebrospinal fluid (CSF), fluid (interstitial or intracellular), and cells (four-part rectangle) result in increases in intracranial pressure and eventual neurologic damage. Elements that are potentially under control of the anesthesiologist are indicated by asterisks. (Control of CSF volume requires the presence of a ventriculostomy catheter.) The herniation pathways are depicted in Figure 53-1 .

  1. The cellular compartment. This compartment is largely the province of the surgeon. However, it may be the anesthesiologist's responsibility to pose a well-placed diagnostic question. When the brain is bulging into the surgical field at the conclusion of evacuation of an extradural hematoma, the clinician should ask whether a subdural or extradural hematoma is present on the contralateral side that warrants either immediate bur holes or immediate postprocedure radiologic evaluation.
  2. The CSF compartment. There is no pharmacologic manipulation of the size of the CSF space whose time course and magnitude are relevant to the neurosurgical operating room. The only relevant means for manipulating the size of this compartment is by drainage. A tight surgical field can sometimes be improved by passage of a brain needle by the surgeon into a lateral ventricle to drain CSF. This maneuver may be relevant in both supratentorial and infratentorial procedures when poor conditions in the posterior fossa are thought to be the result of downward pressure by the contents of the supratentorial space. Lumbar CSF drainage can be used to improve surgical exposure in situations with no substantial hazard of uncal or transforamen magnum herniation.
  3. The fluid compartment. This compartment can be addressed with steroids and diuretics. The use of these agents is discussed in the sections "Management of Blood Pressure" and "Steroids," respectively.
  4. The blood compartment. This is the compartment that receives the anesthesiologist's greatest attention because it is the most amenable to rapid alteration. The blood compartment should be considered two separate components: venous and arterial.


TABLE 53-1 -- Intracranial compartments and techniques for manipulation of their volume
Compartment Volume Control Methods
1. Cells (including neurons, glia, tumors, and extravasated blood) Surgical removal
2. Fluid (intracellular and extracellular) Diuretics

Steroids (principally tumors)
3. Cerebrospinal fluid Drainage
4. Blood
      Arterial side Decrease cerebral blood flow
      Venous side Improve cerebral venous drainage

We suggest giving first consideration to the venous side of the circulation. It is largely a passive compartment that is frequently overlooked. Passive though it is, engorgement of this compartment is a common cause of increased ICP or poor conditions in the surgical field ( Fig. 53-5 ). A head-up posture to ensure good venous drainage is the norm in neurosurgical anesthesia and critical care. Obstruction of cerebral venous drainage by extremes of head position or circumferential pressure (Philadelphia collars, endotracheal tube ties) should be avoided. Phenomena occurring downstream from the venous structures of the neck may also be relevant. Anything that causes increased intrathoracic pressure can result in obstruction of cerebral venous drainage. A variety of


2130


Figure 53-5 Effect of obstruction of cerebral venous outflow on intracranial pressure (ICP) in a patient with intracerebral hematoma. Bilateral jugular compression was applied briefly to verify the function of a newly placed ventriculostomy. The ICP response illustrates the importance of maintaining unobstructed cerebral venous drainage.

commonplace events can lead to obstruction, including kinked or partially obstructed endotracheal tubes, tension pneumothorax, coughing/straining against the endotracheal tube, or gas trapping as a result of bronchospasm. These too should be sought and remedied. Most practitioners carefully maintain paralysis during craniotomies unless a contraindication is present because a sudden cough can result in dramatic herniation of cerebral structures through the craniotomy.

Thereafter, the anesthesiologist should consider the arterial side of the circulation. Attention to the effect of anesthetic drugs and techniques on cerebral blood flow (CBF) (see Chapter 21 ) is an established part of neuroanesthesia. Such attention is relevant because in general, increases in CBF are associated with increases in cerebral blood volume (CBV).[1] [2] [3] The notable exception to this rule occurs in the context of cerebral ischemia caused by hypotension or vessel occlusion, when CBV may increase as the cerebral vasculature dilates in response to a sudden reduction in CBF. However, the relationship generally applies, and attention to the control of CBF is relevant in situations in which volume compensation mechanisms are exhausted or ICP is already increased. The general approach is to select anesthetics and control the physiologic parameters in a manner that avoids unnecessary increases in CBF. The parameters that influence CBF are listed in Table 53-2 and are discussed in Chapter 21 .

Selection of Anesthetics

The question of which anesthetics are appropriate, especially in the context of unstable ICP, arises often. Chapter 21 provides relevant information in detail, and only broad generalizations are made here.

In general, intravenous anesthetic, analgesic, and sedative drugs are associated with parallel reductions in CBF and cerebral metabolic rate (CMR) and will not have adverse effects on ICP. Ketamine, given in large doses to patients with a generally normal level of consciousness before anesthesia, may be the exception. It appears that for the most part, autoregulation and CO2 responsiveness are preserved during the administration of all intravenous drugs ( Chapter 21 ).

By contrast, all of the volatile anesthetics cause dose-dependent cerebral vasodilation. The order of vasodilating potency is approximately halothane ≫ enflurane > isoflurane > desflurane > sevoflurane. As noted in Chapter 21 , the CBF differences among isoflurane, desflurane, and sevoflurane are probably not significant to the clinician. The net CBF effect of introducing a volatile anesthetic will depend on the interaction of several factors: the concentration of the anesthetic, the extent of previous CMR depression, simultaneous blood pressure changes acting in conjunction with previous or anesthetic-induced autoregulation abnormalities, and simultaneous changes in PaCO2 acting in conjunction with any disease-related impairment in CO2 responsiveness.

Nitrous oxide is also a cerebral vasodilator, the CBF effect of which is greatest when it is administered as a sole anesthetic, least when it is administered against a background of narcotics, propofol, or benzodiazepines, and intermediate when administered in conjunction
TABLE 53-2 -- Factors that influence cerebral blood flow *
PaO2
PaCO2
Cerebral metabolic rate
  Arousal/pain
  Seizures
  Temperature
  Anesthetics
Blood pressure/status of autoregulation
Vasoactive agents
  Anesthetics
  Pressors
  Inotropes
  Vasodilators
Blood viscosity
Neurogenic pathways (intra- and extra-axial)
*See Chapter 21 for discussion.






2131
with volatile anesthetics ( Chapter 21 ). Nonetheless, experience dictates that both N2 O and volatile anesthetics, the latter usually in concentrations less than the minimum alveolar concentration (MAC), when administered as components of a balanced anesthetic technique in combination with narcotics, can be used in most elective and many emergency neurosurgical procedures. Exceptions will be rare. When they occur (a somnolent, vomiting patient with papilledema, a large mass, and compressed basal cisterns; a head injury victim with an expanding mass lesion or obliterated cisterns and sulci on CT), the clinician may be well advised to use a predominantly intravenous technique until the cranium and dura are open and the effect of the anesthetic technique can be assessed by direct observation of the surgical field. Inhaled anesthetics will be entirely acceptable components of most anesthetics for neurosurgery. However, in circumstances in which ICP is persistently elevated (in a closed-cranium procedure) or the surgical field is persistently "tight," N2 O and volatile anesthetics should be viewed as potential contributing factors[4] and be eliminated from the anesthetic in favor of intravenous drugs.

Muscle relaxants ( Chapter 13 and Chapter 21 ) that have the potential to release histamine (curare, metocurine, mivacurium, atracurium) should be given in small, divided doses. Although succinylcholine has been associated with increases in ICP, these increases are small and transient. Moreover, the increases can be blocked by a preceding dose of metocurine, 0.03 mg/kg,[5] and in at least some instances, are not evident in patients with common emergency neurosurgical conditions (head injury, subarachnoid hemorrhage [SAH]).[6] Accordingly, in a clinical situation that calls for rapid relaxation for the purpose of controlling or protecting the airway, succinylcholine in conjunction with proper management of the airway and MAP is reasonable.

From the material just presented and the preceding discussion of cerebral physiology in Chapter 21 , a systematic clinical approach should follow readily. A schema for approaching the problem of an acute increase in ICP or acute deterioration in conditions in the surgical field is presented in Table 53-3 .

If the problem has not resolved satisfactorily after following the approach in Table 53-3 , what then? Table 53-4 presents the options.

CSF drainage was discussed earlier. The use of additional osmotic diuretics is theoretically limited by an upper acceptable osmolarity limit of approximately 320 mOsm/L. However, in extremis, the use is frequently empirical, and repeated doses (e.g., 12.5 g) are administered until a clinical response is no longer observed. Barbiturates have long been used most to induce a reduction in CMR, with the objective of causing a coupled reduction in CBF and thereby CBV. Propofol is gaining popularity for this application. Note, however, that although the use of barbiturates is supported by intensive care unit (ICU) experience demonstrating efficacy in control[7] (if not outcome) of ICP, no such experience has been accumulated for propofol. Furthermore, a frequently fatal syndrome of metabolic acidosis and rhabdomyolysis has recently been recognized in patients who have received prolonged propofol infusions in the ICU setting.[8] [9] [10] MAP reduction will occasionally
TABLE 53-3 -- The high—intracranial pressure/"tight-brain" checklist
1. Are the relevant pressures controlled?
   Jugular venous pressure
     Extreme head rotation or neck flexion?
     Direct jugular compression?
     Head-up posture?
   Airway pressure
     Airway obstruction?
     Bronchospasm?
     Straining, coughing, adequately relaxed?
     Pneumothorax?
   Partial pressure of CO2 and O2 (PaCO2 , PaO2 )
   Arterial pressure
2. Is the metabolic rate controlled?
   Pain/arousal?
   Seizures?
3. Are any potential vasodilators in use?
   N2 O, volatile anesthetics, nitroprusside, calcium channel blockers
4. Are there any unrecognized mass lesions?
   Blood, air ± N2 O

reduce vascular engorgement and thereby reduce total brain bulk. This approach is most likely to be relevant in the event of dysautoregulation occurring in the context of resection of arteriovenous malformations (AVMs) (see the later section "Aneurysms and Arteriovenous Malformations").

Previous Next